10-Apr-2019 - Max-Planck-Institut für molekulare Genetik

A molecular switch for the X chromosome

Elucidation of basic mechanism to initiate the inactivation of X chromosomes in female organisms

A large number of genes have to be switched on or off at different times during development. A particular challenge occurs when two copies of the same gene must acquire opposing states of activation within the same cell, as it is the case, for example, for the two X chromosomes in the female organism. Scientists at the Max Planck Institute for Molecular Genetics in Berlin have analyzed this process and developed a basic model for the initiation of X inactivation by the RNA molecule Xist. They found that Xist must be repressed by a factor that also lies on the X chromosome and that can only act on the chromosome on which it is located. For correct regulation of Xist, a second X chromosomal factor is required, that activates all Xist genes regardless of the chromosome on which they are located. The model presents a general mechanism to initiate X chromosome inactivation in various mammalian species and sets the stage for identifying the molecular mechanisms that are required for this process.

In mammals including humans, the genetic sex is determined by the sex chromosomes X and Y. Unlike other chromosomes, X and Y do not form a homologous pair, but contain different genes and often differ in shape and size. Female cells typically have two copies of the same sex chromosome (XX), while males typically have one Y chromosome that determines the male sex, and one X chromosome. Also all other chromosomes are present in pairs, but these autosome pairs carry the same genes.

Gene dosage is the number of identical genes present in an active form in the organism. In mammals, gene dosage is tightly constrained. If genes are missing or additional gene copies are present due to congenital diseases, this can lead to severe disabilities. A well-known example is Down syndrome (trisomy 21), which is caused by the presence of a third copy of chromosome 21 resulting in an increased dose for all its genes in each cell of the organism.

Female and male organisms need the same dose of X-linked genes

The correct gene dosage is also important for the genes carried by the X chromosome. "For normal function, each organism, whether male or female, only needs the gene dosage provided by a single X chromosome," explains Edda Schulz, head of the Max Planck Research Group “Regulatory Networks in Stem Cells” at the Max Planck Institute for Molecular Genetics in Berlin. "However, the female organism usually has two X chromosomes. Thus, it has to ensure that the genes of one X chromosome are switched off or inactivated."

It is exactly this inactivation Schulz is interested in. Together with her team, she investigates how female mammals switch off one of their two X chromosomes in each of their cells, while the single X chromosome in male cells remains active. It has already been known for some time that the genes on the X chromosome are silenced by a long non-coding RNA called Xist. But Xist is located on all X chromosomes. Why is it only effective on one of two X chromosomes in female cells? Why doesn’t Xist silence the genes on the second X chromosome, and why doesn’t it get up-regulated on the single X chromosomes of male cells?

Repressors and activators in cis and trans

It has been shown by numerous studies that Xist is regulated by many different factors. Some regulators suppress Xist (repressors), while others enhance it (activators). Furthermore, some factors only affect genes that lie on the same chromosome as the factor itself – which is called cis regulation. Other factors affect all copies of their target gene, irrespectively of whether they are located on the same or another chromosome. This is called trans-regulation. However, until now no general model existed that could explain how these factors must act together to ensure correct onset of X inactivation.

Mathematical models to simulate X inactivation

Schulz and her team therefore developed a range of mathematical models to systematically screen alternative interaction modes of activators and repressors. They classified the factors involved in different categories, depending on whether they activate or repress Xist, whether they only act on the X chromosome on which they are located or on both X chromosomes in the cell, and whether they were silenced during X inactivation or maintain their function. "Only one of our models can ensure Xist activation on exactly one of two X chromosomes," explains Verena Mutzel, who performed the model simulations. "In order to ensure that one X chromosome remains active in all cells, male and female, the repressor for Xist must be cis-acting, which means, it can only affect a target gene located on the same chromosome as itself. However, to guarantee that only one X chromosome remains active in cells with more than one X chromosome, all X chromosomes must also have a trans-acting activator of Xist"

Double repression allows activity

The scientists checked their model in various cell culture experiments. In addition to male and female cells, they also used cell lines with three or more X chromosomes and genetically modified cell lines, where Xist could be activated on demand. Genes on the X chromosome are repressed by the long non-coding RNA Xist. However, according to their model, Xist itself is also repressed by a factor that is located on the same X chromosome. Therefore, the X chromosome remains active in cells with only one X. In cells with two X chromosomes, the Xist activator acting in trans is present in two copies, which allows it to overcome the repression by the Xist repressor. Thus, Xist becomes active and the genes on the affected X chromosome get silenced. The silencing includes the trans activator on the respective chromosome, so that it cannot inactivate the second X chromosome.

„Interestingly, the model can also explain X inactivation patterns in humans with Turner or Klinefelter syndromes“, Schulz says. Turner syndrome is a congenital disease affecting women, who only have one sex chromosome (X0). Since only a single copy of the trans activator for Xist is present, the genes on the existing X chromosome remain active. Men affected by Klinefelter syndrome possess a second X chromosome in addition to the usual X and Y chromosomes. In these cases, one of the two X chromosomes gets inactivated, as it is the case in female organisms.

Moreover, the model also explains the different Xist patterns that have been described in different mammalian species. "So far it has been suggested that X inactivation is ensured by different mechanisms in different species. However, the differences can also arise from the same regulatory network if the interaction strengths between network components are different. We therefore propose that the regulatory principles employed by different mammalian species are less diverse than previously thought and that different routes to inactivate an X chromosome could arise due to quantitative differences in reaction rates rather than qualitative differences in network architecture”, says Schulz.

  • Verena Mutzel, Ikuhiro Okamoto, Ilona Dunkel, Mitinori Saitou, Luca Giorgetti, Edith Heard, Edda G. Schulz; "A symmetric toggle switch explains the onset of random X inactivation in different mammals"; Nature Structural and Molecular Biology; 2019 [Epub ahead of print]

Facts, background information, dossiers

  • chromosomes
  • X chromosomes

More about MPI für molekulare Genetik

  • News

    How to find marker genes in cell clusters

    The thousands of cells in a biological sample are all different and can be analyzed individually, cell by cell. Based on their gene activity, they can be sorted into clusters. But which genes are particularly characteristic of a given cluster, i.e. what are its “marker genes”? A new statist ... more

    Cell-culture breakthrough: Advanced “mini brains” in the dish

    “Outer Radial Glia” (oRG) cells are nervous system stem cells that are instrumental for the development of the human cortex and have been challenging to produce in the lab. Now, a team of Max Planck researchers from Berlin succeeded in generating brain organoids that are enriched with these ... more

    Unmuting the genome

    Hereditary diseases as well as cancers and cardiovascular diseases may be associated with a phenomenon known as genomic imprinting, in which only the maternally or paternally inherited gene is active. An international research team involving scientists at the Technical University of Munich ... more

More about Max-Planck-Gesellschaft

  • News

    Neuroscientists illuminate how brain cells deep in the cortex operate in freely moving mice

    How can we see what neurons deep in the cortex are doing during behavior? Researchers at the Max Planck Institute for the Neurobiology of Behavior - caesar (MPINB) have developed a miniature microscope small enough to be carried on the head of a freely moving mouse and capable of measuring ... more

    Measuring Organ Development

    Researchers from Dresden and Vienna reveal link between connectivity of three-dimensional structures in tissues and the emergence of their architecture to help scientists engineer self-organising tissues that mimic human organs. Organs in the human body have complex networks of fluid-filled ... more

    Back to the Future of Photosynthesis

    The central biocatalyst in Photosynthesis, Rubisco, is the most abundant enzyme on earth. But how did Rubisco evolve, and how did it adapt to environmental changes during Earth’s history? By reconstructing billion-year-old enzymes, a team of Max Planck Researchers has deciphered one of the ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: